![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inositide Signaling Group, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina
Cells aggressively defend adenosine nucleotide homeostasis; intracellular biosensors detect variations in energetic status and communicate with other cellular networks to initiate adaptive responses. Here, we demonstrate some new elements of this communication process, and we show that this networking is compromised by off-target, bioenergetic effects of some popular pharmacological tools. Treatment of cells with 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR), so as to simulate elevated AMP levels, reduced the synthesis of bis-diphosphoinositol tetrakisphosphate ([PP]2-InsP4), an intracellular signal that phosphorylates proteins in a kinase-independent reaction. This was a selective effect; levels of other inositol phosphates were unaffected by AICAR. By genetically manipulating cellular AMP-activated protein kinase activity, we showed that it did not mediate these effects of AICAR. Instead, we conclude that the simulation of deteriorating adenosine nucleotide balance itself inhibited [PP]2-InsP4 synthesis. This conclusion is consistent with our demonstrating that oligomycin elevated cellular [AMP] and selectively inhibited [PP]2-InsP4 synthesis without affecting other inositol phosphates. In addition, we report that the shortterm increases in [PP]2-InsP4 levels normally seen during hyperosmotic stress were attenuated by 2-(2-chloro-4-iodo-phenylamino)-N-cyclopropylmethoxy-3,4-difluoro-benzamide (PD184352). The latter is typically considered an exquisitely specific mitogen-activated protein kinase kinase (MEK) inhibitor, but small interfering RNA against MEK or extracellular signal-regulated kinase revealed that this mitogen-activated protein kinase pathway was not involved. Instead, we demonstrate that [PP]2-InsP4 synthesis was inhibited by PD184352 through its nonspecific effects on cellular energy balance. Two other MEK inhibitors, 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126) and 2'-amino-3'-methoxyflavone (PD98059), had similar off-target effects. We conclude that the levels and hence the signaling strength of [PP]2-InsP4 is supervised by cellular adenosine nucleotide balance, signifying a new link between signaling and bioenergetic networks.
Received for publication December 21, 2007.
Accepted for publication May 6, 2008.
Address correspondence to: Dr. Stephen B. Shears, Inositide Signaling Group, National Institute of Environmental Health Sciences, NIH, DHHS, P.O. Box 12233, Research Triangle Park, NC 27709. E-mail: shears{at}niehs.nih.gov
This article has been cited by other articles:
|
|
 |
|
  M. Murgia, T. E. Jensen, M. Cusinato, M. Garcia, E. A. Richter, and S. Schiaffino Multiple signalling pathways redundantly control glucose transporter GLUT4 gene transcription in skeletal muscle J. Physiol., September 1, 2009; 587(17): 4319 - 4327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. B. Shears Diphosphoinositol Polyphosphates: Metabolic Messengers? Mol. Pharmacol., August 1, 2009; 76(2): 236 - 252. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Hayes, K. P. Skibicka, K. K. Bence, and H. J. Grill Dorsal Hindbrain 5'-Adenosine Monophosphate-Activated Protein Kinase as an Intracellular Mediator of Energy Balance Endocrinology, May 1, 2009; 150(5): 2175 - 2182. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
